Azelis Group NV (EBR:AZE)
10.31
-0.05 (-0.48%)
May 22, 2026, 5:38 PM CET
Azelis Group NV Revenue
In the year 2025, Azelis Group NV had annual revenue of 4.11B EUR, down -2.45%. Azelis Group NV had revenue of 1.95B in the half year ending December 31, 2025, a decrease of -2.94%.
Revenue
4.11B
Revenue Growth
-2.45%
P/S Ratio
0.61
Revenue / Employee
1.03M
Employees
4,001
Market Cap
2.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.11B | -103.23M | -2.45% |
| Dec 31, 2024 | 4.21B | 61.79M | 1.49% |
| Dec 31, 2023 | 4.15B | 43.12M | 1.05% |
| Dec 31, 2022 | 4.11B | 1.28B | 45.34% |
| Dec 31, 2021 | 2.83B | 604.40M | 27.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Colruyt Group | 11.19B |
| Proximus | 6.13B |
| Solvay | 4.65B |
| NV Bekaert | 3.71B |
| Fagron NV | 952.17M |
| Melexis NV | 843.46M |
| Shurgard Self Storage | 450.85M |
| Cofinimmo | 383.10M |
Azelis Group NV News
- 7 days ago - Azelis price target raised to EUR 12 from EUR 10.50 at Morgan Stanley - TheFly
- 4 weeks ago - Azelis Group NV Earnings Call Transcript: Q1 2026 - Transcripts
- 4 weeks ago - Azelis Group NV Earnings release: Q1 2026 - Filings
- 4 weeks ago - Azelis Group NV Slides: Q1 2026 - Filings
- 4 weeks ago - Azelis Group NV: Q1 2026 Results: Strong Cash Generation in Volatile Markets - Business Wire
- 3 months ago - Azelis price target lowered to EUR 15 from EUR 17.50 at Goldman Sachs - TheFly
- 3 months ago - Azelis price target raised to EUR 10.50 from EUR 10 at Barclays - TheFly
- 3 months ago - Azelis Group NV Earnings Call Transcript: H2 2025 - Transcripts